Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
Amsterdam UMC Location University of Amsterdam · Hartford Hospital · +29 more institutions
Abstract
Statin-associated muscle symptoms (SAMS) are one of the principal reasons for statin non-adherence and/or discontinuation, contributing to adverse cardiovascular outcomes. This European Atherosclerosis Society (EAS) Consensus Panel overviews current understanding of the pathophysiology of statin-associated myopathy, and provides guidance for diagnosis and management of SAMS. Statin-associated myopathy, with significant elevation of serum creatine kinase (CK), is a rare but serious side effect of statins, affecting 1 per 1000 to 1 per 10 000 people on standard statin doses. Statin-associated muscle symptoms cover a broader range of clinical presentations, usually with normal or minimally elevated CK levels,…
Citation impact
- FWCI
- 143.34
- Percentile
- 100%
- References
- 125
Authors
55Topics & keywords
- Medicine
- Statin
- myalgia
- Discontinuation
- Myopathy
- Internal medicine
- Atorvastatin
- Physical therapy
- Affordable and clean energy